Consistently, NLRP3 levels were also increased in microglia around Aβ plaques in AD patients, compared with their levels in control groups, suggesting NLRP3 might also involve in microglial activation and Aβ pathology in the development of AD in clinic. Here, NLRP3 is linked to Alzheimer disease.